$PZG
Paramount Gold Nevada Corp

2018 Form 10-K Financial Statement

#000156459018022959 Filed on September 11, 2018

View on sec.gov

Income Statement

Concept 2018 2017 Q4 2017 Q3
Revenue $344.6K $0.00 $85.55K
YoY Change 22.79% -100.0% 1512.29%
Cost Of Revenue $519.6K $120.0K $160.0K
YoY Change -18.3% 0.0% 6.67%
Gross Profit -$175.0K -$120.0K -$80.00K
YoY Change -50.75% 50.0% -46.67%
Gross Profit Margin -50.76% -93.51%
Selling, General & Admin $1.415M $330.0K $300.0K
YoY Change -16.6% -15.38% -40.0%
% of Gross Profit
Research & Development $4.223M $1.310M $650.0K
YoY Change -21.42% -0.76% 20.37%
% of Gross Profit
Depreciation & Amortization $3.730K $0.00 $938.00
YoY Change -21.7% -100.0% -14.88%
% of Gross Profit
Operating Expenses $5.910M $1.700M $1.170M
YoY Change -26.06% -5.03% -7.89%
Operating Profit -$6.085M -$1.821M -$1.085M
YoY Change -21.1% -2.47% -14.26%
Interest Expense $16.57K $0.00 $0.00
YoY Change 34.39%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00
YoY Change -100.0% -100.0%
Pretax Income -$6.068M -$1.819M -$1.083M
YoY Change -19.68% -0.33% -14.2%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$6.068M -$1.819M -$1.083M
YoY Change 39.83% -0.33% -155.42%
Net Earnings / Revenue -1760.77% -1265.63%
Basic Earnings Per Share -$0.28 -$0.08 -$0.06
Diluted Earnings Per Share -$0.28 -$0.08 -$0.06
COMMON SHARES
Basic Shares Outstanding 21.57M 22.38M 17.78M
Diluted Shares Outstanding 21.57M 22.38M 17.78M

Balance Sheet

Concept 2018 2017 Q4 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $297.4K $5.230M $90.00K
YoY Change -84.44% 188.95% -97.58%
Cash & Equivalents $297.4K $5.227M $90.00K
Short-Term Investments
Other Short-Term Assets $260.4K $390.0K $198.0K
YoY Change 21.91% -7.14% -64.0%
Inventory
Prepaid Expenses
Receivables $0.00 $20.00K $100.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $557.8K $5.633M $929.1K
YoY Change -73.94% 150.34% -78.29%
LONG-TERM ASSETS
Property, Plant & Equipment $48.87M $10.78K $11.72K
YoY Change 5.16% -27.33% -99.97%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.770M $2.010M $2.090M
YoY Change -15.2% -12.23% -11.06%
Total Long-Term Assets $50.64M $48.49M $48.56M
YoY Change 4.28% -0.58% -0.55%
TOTAL ASSETS
Total Short-Term Assets $557.8K $5.633M $929.1K
Total Long-Term Assets $50.64M $48.49M $48.56M
Total Assets $51.20M $54.12M $49.49M
YoY Change 0.98% 6.08% -6.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $928.0K $560.0K $700.0K
YoY Change 6.28% 124.0% 29.63%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.030M $697.6K $920.0K
YoY Change -5.48% 10.74% 0.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $971.0K $1.120M $1.080M
YoY Change -7.08% 9.8% 2.86%
Total Long-Term Liabilities $971.0K $1.120M $1.080M
YoY Change -7.08% 9.8% 2.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.030M $697.6K $920.0K
Total Long-Term Liabilities $971.0K $1.120M $1.080M
Total Liabilities $2.001M $1.818M $2.000M
YoY Change -6.26% 9.51% 1.01%
SHAREHOLDERS EQUITY
Retained Earnings -$38.56M
YoY Change
Common Stock $90.86M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $49.20M $52.30M $47.49M
YoY Change
Total Liabilities & Shareholders Equity $51.20M $54.12M $49.49M
YoY Change 0.98% 6.07% -6.81%

Cashflow Statement

Concept 2018 2017 Q4 2017 Q3
OPERATING ACTIVITIES
Net Income -$6.068M -$1.819M -$1.083M
YoY Change 39.83% -0.33% -155.42%
Depreciation, Depletion And Amortization $3.730K $0.00 $938.00
YoY Change -21.7% -100.0% -14.88%
Cash From Operating Activities -$5.841M -$1.690M -$1.819M
YoY Change -10.37% -11.05% 56.83%
INVESTING ACTIVITIES
Capital Expenditures -$2.400M $0.00
YoY Change 94761.66%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$2.400M $0.00 $0.00
YoY Change 138.78% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $6.627M
YoY Change 86.23%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.627M 6.820M 0.000
YoY Change 86.23%
NET CHANGE
Cash From Operating Activities -5.841M -1.690M -1.819M
Cash From Investing Activities -2.400M 0.000 0.000
Cash From Financing Activities 6.627M 6.820M 0.000
Net Change In Cash -1.614M 5.130M -1.819M
YoY Change -59.28% -370.0% -15.78%
FREE CASH FLOW
Cash From Operating Activities -$5.841M -$1.690M -$1.819M
Capital Expenditures -$2.400M $0.00
Free Cash Flow -$3.441M -$1.690M
YoY Change -47.18% -11.05%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q2 us-gaap Other Assets Current
OtherAssetsCurrent
16292
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-6068154
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2017 pzg Gain Loss On Sale Of Mineral Property
GainLossOnSaleOfMineralProperty
100000
CY2017 pzg Non Recurring Rebates
NonRecurringRebates
44633
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6068154
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7555020
CY2017 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-3215418
CY2018 us-gaap Asset Retirement Obligation Liabilities Settled
AssetRetirementObligationLiabilitiesSettled
339219
CY2018Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
1072551
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21566242
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
54835
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
697326
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5840679
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6516457
CY2017 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
1006964
CY2018 us-gaap Payments To Acquire Mineral Rights
PaymentsToAcquireMineralRights
2400000
CY2017 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
4363
CY2017 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
2527
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2400000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1005128
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6626898
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3558497
CY2017 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
38225
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21566242
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
243421
CY2017 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
15202866
CY2017 pzg Stock Issued During Period Value Private Placement
StockIssuedDuringPeriodValuePrivatePlacement
3553156
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
71335
CY2018 pzg Stock Issued During Period Value Private Placement
StockIssuedDuringPeriodValuePrivatePlacement
6626898
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6068154
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
71335
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
243421
CY2018 us-gaap Reclamation And Mine Shutdown Provision
ReclamationAndMineShutdownProvision
-22158
CY2017 us-gaap Reclamation And Mine Shutdown Provision
ReclamationAndMineShutdownProvision
-14724
CY2017 pzg Amortization Of Prepaid Insurance Expenses
AmortizationOfPrepaidInsuranceExpenses
24517
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-15804
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15804
CY2018 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
16292
CY2018 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
30517
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6626898
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3558497
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1613781
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3963088
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5874258
CY2018 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-1609037
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of these consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Significant estimates made by management in the accompanying consolidated financial statements include the adequacy of the Company&#8217;s asset retirement obligations, valuation of deferred tax asset, and assessment of impairment of mineral properties.</p></div>
CY2018 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash and cash equivalents and accounts receivable.&nbsp;&nbsp;The Company maintains cash in accounts which may, at times, exceed federally insured limits.&nbsp;&nbsp;At June 30, 2018, there were no balances that were in excess of federally insured limits.&nbsp;&nbsp;We deposit our cash with financial institutions which we believe have sufficient credit quality to minimize the risk of loss.</p></div>
CY2018Q2 pzg Concentration Of Credit Risk Uninsured Cash Amount
ConcentrationOfCreditRiskUninsuredCashAmount
0
CY2018 pzg Cash Uninsured Amount Description
CashUninsuredAmountDescription
We deposit our cash with financial institutions which we believe have sufficient credit quality to minimize the risk of loss
CY2018 us-gaap Nonmonetary Transaction Amount Of Barter Transaction
NonmonetaryTransactionAmountOfBarterTransaction
0
CY2017Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
2090000
CY2017Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.75
CY2017Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3657500
CY2018 pzg Sale Of Equity Units Description Of Transaction
SaleOfEquityUnitsDescriptionOfTransaction
Each unit consists of one share of common stock and one warrant to purchase one-half of a share of common stock.
CY2018 pzg Class Of Warrant Or Right Description
ClassOfWarrantOrRightDescription
Each warrant will have a two-year term and is exercisable at the following exercise prices: in the first year at $2.00 per share or in the second year at $2.25 per share.
CY2017Q1 pzg Adjustments To Additional Paid In Capital Issuance Of Units
AdjustmentsToAdditionalPaidInCapitalIssuanceOfUnits
3532256
CY2017Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
473658
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
557329
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.23
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.78
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.79
CY2018Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
330071
CY2018 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y8M12D
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
0
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
6800
CY2017Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
1261034
CY2016Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
1402039
CY2017 us-gaap Asset Retirement Obligation Liabilities Settled
AssetRetirementObligationLiabilitiesSettled
278293
CY2018 us-gaap Insurance Recoveries
InsuranceRecoveries
339219
CY2017 us-gaap Insurance Recoveries
InsuranceRecoveries
275365
CY2018 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
5413
CY2017 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
5306
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3400
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1274312
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2568707
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
78
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
171
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2017Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2016Q3 us-gaap Revenues
Revenues
5306
CY2016Q4 us-gaap Revenues
Revenues
40599
CY2017Q1 us-gaap Revenues
Revenues
237694
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1265014
CY2016Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1867372
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
1953496
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
-1824892
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2017 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-1866223
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1712825
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3215418
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3215418
CY2018 us-gaap Income Tax Examination Year Under Examination
IncomeTaxExaminationYearUnderExamination
2010 2011 2012 2013 2014 2015 2016 2017
CY2017Q3 us-gaap Revenues
Revenues
85548
CY2018Q1 us-gaap Revenues
Revenues
22260
CY2017Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1821217
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1665511
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-1818890
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-1658748
CY2017Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2016Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2016Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
10152
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
10364
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
10575

Files In Submission

Name View Source Status
0001564590-18-022959-index-headers.html Edgar Link pending
0001564590-18-022959-index.html Edgar Link pending
0001564590-18-022959.txt Edgar Link pending
0001564590-18-022959-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gho2egvlb2wz000001.jpg Edgar Link pending
gho2egvlb2wz000002.jpg Edgar Link pending
gho2egvlb2wz000003.jpg Edgar Link pending
gho2egvlb2wz000004.jpg Edgar Link pending
gho2egvlb2wz000005.jpg Edgar Link pending
gho2egvlb2wz000006.jpg Edgar Link pending
gho2egvlb2wz000007.jpg Edgar Link pending
gpnu4541kohf000001.jpg Edgar Link pending
gpnu4541kohf000002.jpg Edgar Link pending
pzg-10k_20180630.htm Edgar Link pending
pzg-20180630.xml Edgar Link completed
pzg-20180630.xsd Edgar Link pending
pzg-20180630_cal.xml Edgar Link unprocessable
pzg-20180630_def.xml Edgar Link unprocessable
pzg-20180630_lab.xml Edgar Link unprocessable
pzg-20180630_pre.xml Edgar Link unprocessable
pzg-ex211_10.htm Edgar Link pending
pzg-ex231_8.htm Edgar Link pending
pzg-ex311_12.htm Edgar Link pending
pzg-ex312_7.htm Edgar Link pending
pzg-ex321_9.htm Edgar Link pending
pzg-ex322_11.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending